Literature DB >> 2191297

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.

E O Freed1, D J Myers, R Risser.   

Abstract

The human immunodeficiency virus transmembrane glycoprotein gp41 has at its amino terminus a strongly hydrophobic stretch of 28 amino acids flanked by a highly conserved series of polar amino acids. To investigate the role in syncytium formation of the hydrophobic amino terminus of gp41 and the polar border of this hydrophobic region, we introduced eight single-amino acid substitutions and one double-amino acid substitution in the amino-terminal 31 amino acids of gp41. The mutant envelope glycoproteins were expressed from two distinct human immunodeficiency virus type 1 envelope glycoprotein expression vectors; the effects of the mutations on syncytium formation, envelope glycoprotein transport, secretion, and CD4 receptor-binding were analyzed. Results showed that polar substitutions throughout the hydrophobic amino terminus of gp41 greatly reduced or blocked syncytium formation mediated by the human immunodeficiency virus type 1 envelope glycoproteins, as did nonconservative mutations in the polar border of the hydrophobic amino terminus. Mutations at gp41 amino acids 15, 26, and 29 also significantly increased the extent of gp120 secretion into the extracellular medium. None of the mutations detectably affected envelope glycoprotein processing or envelope glycoprotein binding to CD4.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191297      PMCID: PMC54174          DOI: 10.1073/pnas.87.12.4650

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

2.  Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus.

Authors:  M A Bratt; W R Gallaher
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

3.  Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.

Authors:  M J Zoller; M Smith
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

Review 4.  Membrane fusion proteins of enveloped animal viruses.

Authors:  J White; M Kielian; A Helenius
Journal:  Q Rev Biophys       Date:  1983-05       Impact factor: 5.318

5.  Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion.

Authors:  J White; A Helenius; M J Gething
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

8.  Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.

Authors:  E O Freed; D J Myers; R Risser
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Isolation of naturally occurring viruses of the murine leukemia virus group in tissue culture.

Authors:  J W Hartley; W P Rowe; W I Capps; R J Huebner
Journal:  J Virol       Date:  1969-02       Impact factor: 5.103

10.  Oligopeptides that specifically inhibit membrane fusion by paramyxoviruses: studies on the site of action.

Authors:  C D Richardson; P W Choppin
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

View more
  159 in total

1.  Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.

Authors:  X Yang; L Florin; M Farzan; P Kolchinsky; P D Kwong; J Sodroski; R Wyatt
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  A theoretical investigation into the lipid interactions of m-calpain.

Authors:  A Daman; F Harris; S Biswas; J Wallace; D A Phoenix
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

3.  Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.

Authors:  T Suárez; W R Gallaher; A Agirre; F M Goñi; J L Nieva
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation.

Authors:  Shantaram Kamath; Tuck C Wong
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

5.  Analysis of local conformation of membrane-bound and polycrystalline peptides by two-dimensional slow-spinning rotor-synchronized MAS exchange spectroscopy.

Authors:  Charles M Gabrys; Jun Yang; David P Weliky
Journal:  J Biomol NMR       Date:  2003-05       Impact factor: 2.835

6.  Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.

Authors:  Michael W Maddox; Marjorie L Longo
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

7.  gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections.

Authors:  Jingjing Ma; Junli Jia; Xuefeng Jiang; Mengyuan Xu; Jinfeng Guo; Tian Tang; Xianyi Xu; Zhisheng Wu; Benshun Hu; Kun Yao; Lingyun Li; Huamin Tang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

8.  Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.

Authors:  M Thali; J P Moore; C Furman; M Charles; D D Ho; J Robinson; J Sodroski
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.

Authors:  A C Andeweg; P Leeflang; A D Osterhaus; M L Bosch
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus.

Authors:  G M Taylor; Y Gao; D A Sanders
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.